BVS Logo

Bioventus Inc. (BVS) 

NASDAQ
Market Cap
$767.42M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
151 of 968
Rank in Industry
16 of 120

Largest Insider Buys in Sector

BVS Stock Price History Chart

BVS Stock Performance

About Bioventus Inc.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Insider Activity of Bioventus Inc.

Over the last 12 months, insiders at Bioventus Inc. have bought $901,702 and sold $389,358 worth of Bioventus Inc. stock.

On average, over the past 5 years, insiders at Bioventus Inc. have bought $2.89M and sold $595,907 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Bartholdson John A. () — $901,702.

The last purchase of 25,500 shares for transaction amount of $217,966 was made by Bartholdson John A. () on 2024‑08‑19.

List of Insider Buy and Sell Transactions, Bioventus Inc.

2024-08-19Purchase
25,500
0.0418%
$8.55$217,966+44.38%
2024-08-16Purchase
80,000
0.1383%
$8.55$683,736+1.25%
2024-06-21SaleSVP & General Counsel
5,904
0.0079%
$5.57$32,885+97.80%
2024-06-21SaleSVP & CFO
9,219
0.0123%
$5.57$51,350+97.80%
2024-06-21SaleSVP & Chief Compliance Officer
2,559
0.0034%
$5.57$14,254+97.80%
2024-06-17SaleSVP & General Counsel
11,308
0.0158%
$5.84$66,039+88.05%
2024-06-17SaleSVP & CFO
13,753
0.0193%
$5.84$80,318+88.05%
2024-06-17SaleSVP & Chief Compliance Officer
8,759
0.0123%
$5.84$51,153+88.05%
2024-04-11SaleSVP & General Counsel
3,054
0.0048%
$4.75$14,507+57.17%
2024-04-11SaleSVP & CFO
4,000
0.0062%
$4.75$19,000+57.17%
2024-04-11SaleSVP & Chief Compliance Officer
1,325
0.0021%
$4.75$6,294+57.17%
2024-03-22SaleSVP & CFO
5,541
0.0087%
$5.39$29,853+32.08%
2024-03-15SaleSVP & General Counsel
3,125
0.0049%
$5.46$17,063+29.72%
2024-03-15SaleSVP & Chief Compliance Officer
1,217
0.0019%
$5.46$6,645+29.72%
2023-08-18PurchaseInterim CEO
39,885
0.0603%
$4.14$165,076+7.76%
2023-08-14Purchase10 percent owner
14,985
0.0242%
$4.79$71,778-1.05%
2023-08-14Purchase
14,985
0.0242%
$4.79$71,753-1.05%
2023-08-11Purchase10 percent owner
50,037
0.0807%
$4.56$228,169+3.76%
2023-08-11Purchase
50,037
0.0813%
$4.60$229,935+3.76%
2023-08-10Purchase10 percent owner
111,848
0.1762%
$4.47$499,961+2.41%

Insider Historical Profitability

22.07%
Bartholdson John A.
6939357
10.6159%
$11.74110+55.37%
D'Adamio AnthonySVP & General Counsel
95576
0.1462%
$11.7417<0.0001%
Singleton Mark LeonardSVP & CFO
84895
0.1299%
$11.7405
CHURCH KATRINA JSVP & Chief Compliance Officer
41199
0.063%
$11.74110<0.0001%
Juniper Investment Company, LLC10 percent owner
6833857
10.4545%
$11.7430
HAWKINS WILLIAM Adirector
184310
0.282%
$11.7420+54.75%
Pavesio AlessandraSVP & Chief Science Officer
148309
0.2269%
$11.7412<0.0001%
Bihl Anthony P IIIInterim CEO
138290
0.2116%
$11.7420+64.61%
Nosenzo JohnFmr. Chief Commercial Officer
87148
0.1333%
$11.7415<0.0001%
Anglum Gregory O.SVP & CFO
55013
0.0842%
$11.7411<0.0001%
Reali Kenneth MichaelChief Executive Officer
30085
0.046%
$11.7421<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Essex Woodlands Management Inc$67.71M16.3613.02M0%+$019.68
Juniper Investment Company$35.54M8.586.83M0%+$017.68
Nantahala Capital Management Llc$30.19M7.295.81M-2.87%-$891,586.791.41
The Vanguard Group$6.34M1.531.22M0%+$0<0.0001
Millennium Management LLC$2.86M0.69549,432+133.32%+$1.63M<0.01
BlackRock$2.77M0.67532,813+5.39%+$141,642.77<0.0001
Morgan Stanley$2.31M0.56445,047+129.96%+$1.31M<0.0001
Geode Capital Management$2.21M0.53424,764+4.25%+$90,081.79<0.0001
Jane Street Capital$2M0.48384,875+147.27%+$1.19M<0.01
Bridgeway Capital Management$1.63M0.39313,804-13.74%-$260,000.030.02
Jacobs Levy Equity Management$1.55M0.37298,015-9.37%-$160,232.800.01
Qube Research & Technologies$1.51M0.37291,213+63.18%+$586,320.95<0.01
Susquehanna International Group$1.51M0.36289,643+13.26%+$176,368.45<0.01
Marshall Wace$1.25M0.3240,448+26.13%+$259,027.68<0.01
LSV Asset Management$1.17M0.28225,027New+$1.17M<0.01
Goldman Sachs$1.11M0.27214,329+523.3%+$935,703.77<0.0001
Charles Schwab$965,385.000.23185,651+2.83%+$26,545.99<0.0001
Alberta Investment Management Corporation$791,580.000.19152,227New+$791,580.000.01
Two Sigma Advisers LP$734,406.000.18141,232+10.4%+$69,159.96<0.01
Mariner Llc$707,751.000.17136,106+4.23%+$28,703.99<0.01
Citigroup$675,267.000.16129,859+4.29%+$27,747.21<0.01
Kennedy Capital Management Inc$624,697.000.15120,134+66.8%+$250,177.280.01
Laurion Capital Management LP$615,113.000.15118,2910%+$0<0.01
Stephens Inc.$602,290.000.15115,825-18.82%-$139,620.000.01
Man Group Plc$587,111.000.14112,906+62.05%+$224,806.32<0.01
State Street$578,209.000.14111,1940%+$0<0.0001
Citadel Advisors LLC$578,916.000.14111,330+43.46%+$175,370.00<0.0001
JPMorgan Chase$553,831.000.13106,506+87.48%+$258,424.31<0.0001
Two Sigma$549,536.000.13105,680+24.39%+$107,754.40<0.01
LOUNTZIS ASSET MANAGEMENT, LLC$520,000.000.13100,0000%+$00.25
Renaissance Technologies$522,000.000.13100,334-25.81%-$181,628.78<0.01
Envestnet Asset Management Inc$475,108.000.1291,3670%+$0<0.0001
Comerica$457,600.000.1188,0000%+$0<0.01
Northern Trust$411,138.000.179,065-11.24%-$52,072.80<0.0001
Hrt Financial Llc$404,000.000.177,808New+$404,000.00<0.01
Marathon Trading Investment Management Llc$333,320.000.0864,100New+$333,320.000.07
Dimensional Fund Advisors$304,418.000.0758,542+89.73%+$143,967.01<0.0001
Balyasny Asset Management Llc$279,219.000.0753,696-38.22%-$172,702.28<0.01
Cubist Systematic Strategies$259,074.000.0649,822+26.38%+$54,074.72<0.01
Jump Financial Llc$261,716.000.0650,330+116.94%+$141,076.00<0.01
Point72 Asia Singapore Pte Ltd$260,140.000.0650,027+4,691.86%+$254,711.210.03
Bank of America$252,746.000.0648,605-27.38%-$95,290.00<0.0001
Bailard Inc$240,115.000.0646,176-20.7%-$62,675.550.01
American Century Investments$225,810.000.0643,425-59.38%-$330,137.60<0.0001
LINSCO PRIVATE LEDGER CORP$208,120.000.0540,023-5.32%-$11,700.02<0.0001
Advisor Group Holdings Inc$199,160.000.0538,300+0.79%+$1,560.00<0.0001
Hillsdale Investment Management Inc.$180,658.000.0434,742+26.14%+$37,439.920.01
Barclays$178,000.000.0434,302-42.44%-$131,234.91<0.0001
Y Intercept Hong Kong Ltd$138,653.000.0326,664+66.25%+$55,255.280.01
Moran Wealth Management Llc$124,426.000.0323,928-1.44%-$1,814.81<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.